Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Articles

Vol. 2 No. 1 (2011): January – March 2011

Synthesis and Biological Evaluation of some 2,5-Disubstituted -1,3,4- Oxadiazole Derivatives

DOI
https://doi.org/10.37285/ijddd.2.1.8
Submitted
November 28, 2024
Published
2024-12-08

Abstract

Synthesis of some new 2, 5-diaryl-1, 3, 4-oxadiazole derivatives starting from Isoniazide (INH) is described. The target compounds 11- 20 were obtained by treating INH with various aromatic aldehydes and monosaccharides to give corresponding Schiff ’s bases 1- 10, which upon subsequent oxidation, by using either method A, B or C, yielded desired compounds. They were purified and characterized by spectroscopic techniques and elemental analyses. These compounds were evaluated for antibacterial, antifungal and antiviral activities. Compounds 11, 16 and 17 exhibited good antibacterial and antifungal activity, however, none of the compounds were enough active against various strains of virus.

References

  1. [1] Frank, P.V.; Girish, K.S.; Kalluraya, B. J. Chem. Sci., 2007, 119, 41. (b) A. A. Kadi, N. R. El-Brollosy, O. A. Al-Deeb, E. E. Habib, T.M. Ibrahim, A. A. El-Emam. Eur. J. Med. Chem., 2007, 42, 235-242.
  2. [2] Ouyang, X.; Patnitski, E. Bioorg. Med. Chem. Letter. 2006, 16, 1191-1196.
  3. [3] Haddy, Z.; Toth, M.; Somsak, L. Arkivoc. 2004, vii, 140-149.
  4. [4] Dhoel SR, Bhimani AS, Khunt RC, Parikh AR. Ind. J. Het Chem. 2005, 15, 63- 64.
  5. [5] Kennedy, A.D.; Summers, A. J. Hererocycl. Chem., 1981, 18, 409.
  6. [6] Holla, B.S.; Prasanna, C.S.; Bhat, U.G. Ind. J. Chem., 2004, 43B, 864.
  7. [7] Raj, M.P.; Rao, J.T. Asian J. Chem., 2003, 25, 492.
  8. [8] Kucukguzel, G.S. Euro. J. Med. Chem., 2002, 37, 197.
  9. [9] Tripathi RP, Saxena N, Tivari VK, Chaturveti V, Manju YK, Shrivastava AK, Sinha S, Bioorg. Med. Chem, 2006, 14, 8186.
  10. [10] Kiselyov, A.S.; Semenova, M.; Semenov, V.V.; Milligan,D. Bioorg. Med. Chem. Lett., 2006, 16, 1913.
  11. [11] Khan, M.T.H.; Choudhary, M.I.; Khan, K.M.; Rani, M.; Rahman, A. Bioorg. Med. Chem., 2005, 13, 3385.
  12. [12] Liszkiewicz, H.; Kolaska, M.W. et al. Ind. J. Chem., 2003, 42B, 2846.
  13. [13] Ouyang, X.; Piatnitski, E.L.; Pattaropong, V.; Chen, X.; He, H.; Kiselyov, A.S.; Gerlak, J.; Wang, Y.; Rosler,R. L.; Zhou, K.; Mitelman, S.; Camara, M.; Surguladze, D.; Doodyb, J.F.; Tumab, M.C. Bioorg. Med. Chem. Lett., 2006, 16, 1191.
  14. [14] a) Kulkarni, Y.D.; Srivastava, D.; Bishnoi, A.; Dua, P.R.J. Ind. Chem. Soc., 1996, 73, 173. b) Vinci, P.; Geronikaki, A.; Incerti, M.; Busonera, B.; Poni, G.; Cabras, C.A.; Colaa, P.L. Bioorg. Med. Chem., 2003, 11, 4785. c) Sharma, S.; Srivastava, V.K.; Kumar, A. Eur. J. Med. Chem., 2002, 37, 689.
  15. [15] Somani, R.R.; Shirodkar, P.Y.; Kadam, V.J. Asian J. Chem., 2008, 20, 6189.
  16. [16] Somani, R.R.; Shirodkar, P.Y.; Toraskar, M.P.; Kadam,V. J. Ind. J. Pharm. Edu. Res., 2008, 42 (1), 53.
  17. [17] a) Sheban, M. A. E. Adv. Heterocycl. Chem. 1998, 70, 163–337. b) Gervay, J.; Flaherrty, T. M.; Holmes, D. Tetrahedron 1997, 53, 16355–16364. c) El Ashry, E. H.; El Kilany, Y. Adv. Heterocycl. Chem. 1998, 69, 129–215.
  18. [18] Rollas, S.; Gulerman, N.; Erdeniz, H. II Farmaco, 2002, 57, 171.
  19. [19] Rao, V.S.; Chandra Sekhar, K.V.G. Synth. Commun., 2004, 34, 2153.
  20. [20] a) Reddy, P.S.N.; Reddy, P.P. Ind. J. Chem., 1987, 26B,
  21. 890. b) Rostamizadeh, S.; Ghasem-Housaini, S.A. Tetrahedron Lett., 2004, 45, 8753, c).Mullican, N.D.; Wilson, M.W.; Connar, D.T. J. Med. Chem., 1993, 5, 103 , d) Pradeep Mishra, Harish Rajak, and Archana Mehta, J. Gen. Appl. Microbiol., 2005, 51, 133–141.
  22. [21] Barry, A L ; The Antimicrobial Test: Principle and Practice, Lea & Febiger, Philadelphia, 1976, 180.
  23. [22] R. Pauwels, Balzarini, J.;, M. Baba, R. Snoeck, D. Schols,P. Herdewijn, J. Desmyter; Clercq, E.; J. Virological Methods, 1988, 20, 309-321.
  24. [23] Clercq, E.; Desgranges, C.; Herdewijn, P.; Sim, I.S.; Jones, A.S.; McLean, M. J.; Walker, R.T. J. Med. Chem., 1986, 29, 213.